MADISON, Wis. (AP) — Wisconsin will get just under $7 million in a settlement drugmaker Eli Lilly and Company reached with multiple states over allegations it improperly marketed an anti-psychotic drug. The state Justice Department said that between September 1999 and January 2006, Eli Lilly promoted a medication called Zyprexa for uses not approved by the U.S. Food and Drug Administration. The company said the drug could treat depression, anxiety, nauseau and gambling addiction. The Justice Department said Eli Lilly agreed to pay the states and federal government $800 million in damages and penalties to Medicaid and other federal health care programs. Wisconsin will get $6.8 million and the federal government $7.2 million for damages to the state's Medicaid program.